MedPath

Gruppo Italiano Malattie EMatologiche dell'Adulto

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.

Phase 2
Conditions
Acute Lymphoblastic Leukemia
Interventions
Drug: High-dose anthracycline
First Posted Date
2007-02-26
Last Posted Date
2018-10-23
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Registration Number
NCT00439920

PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS

Phase 2
Completed
Conditions
Myelodysplastic Syndromes
First Posted Date
2007-02-26
Last Posted Date
2018-08-07
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
62
Registration Number
NCT00439673
Locations
🇮🇹

Ospedale Reg. A di Summa, Brindisi, Italy

🇮🇹

Ospedale A. Businco, Cagliari, Italy

🇮🇹

Università degli studi di Roma La Cattolica, Roma, Italy

and more 4 locations

Velcade in Myelodysplastic Syndrome - Pilot Study

Phase 2
Terminated
Conditions
MDS
First Posted Date
2007-02-26
Last Posted Date
2015-04-23
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
28
Registration Number
NCT00440076
Locations
🇮🇹

Centro Oncologico Basilicata, Rionero in Vulture, Potenza, Italy

🇮🇹

Istituto di Ematologia e Oncologia Medica L. e A. Seragnoli, Bologna, Italy

🇮🇹

Ospedale Niguarda "Ca Grande", Milano, Italy

and more 1 locations

Treatment of Adult Ph+ LAL With BMS-354825

Phase 2
Completed
Conditions
Lymphoblastic Leukemia, Acute
First Posted Date
2006-10-25
Last Posted Date
2017-01-04
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
53
Registration Number
NCT00391989
Locations
🇮🇹

Presidio Ospedaliero "C. e G.Mazzoni", Ascoli Piceno, Italy

🇮🇹

Ist.Ematologia e Oncologia Medica L.e A. Seragnoli, Bologna, Italy

🇮🇹

Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna, Ferrara, Italy

and more 33 locations

STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia

Phase 2
Completed
Conditions
Acute Lymphoblastic Leukemia
First Posted Date
2006-09-14
Last Posted Date
2014-02-07
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
105
Registration Number
NCT00376467
Locations
🇮🇹

Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy

🇮🇹

Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy

🇮🇹

Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy

and more 25 locations
© Copyright 2025. All Rights Reserved by MedPath